Pfizer Gains Victory In Irish Lipitor Case
The decision, handed down on Tuesday by the High Court in Dublin, prohibits Ranbaxy from producing a generic version of atorvastatin, the active ingredient in Lipitor, until 2011, when Pfizer's patents for the drug expire.
Pfizer applauded the court's decision.
“Today's decision is yet another affirmation of the strength of the intellectual...
To view the full article, register now.